Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Biliary Tract Neoplasms 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

Azacitidine 7 venetoclax 6 Specimen Handling 6 Biopsy 6 Injections 5 Stem Cell Transplantation 4 Decitabine 4 Cytarabine 4 fludarabine 3 Cyclophosphamide 3 olutasidenib 2 fludarabine phosphate 2 decitabine and cedazuridine drug combination 2 cedazuridine 2 X-Rays 2 Whole-Body Irradiation 2 Vorinostat 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cyclosporins 2 Cyclosporine 2 Cladribine 2 Carboplatin 2 CPX-351 2 veliparib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡